PE anti-human FLT3L Antibody

Pricing & Availability
Clone
W19353A (See other available formats)
Regulatory Status
RUO
Other Names
FLT3LG, Fms related receptor tyrosine kinase 3 ligand, Fms-like tyrosine kinase 3 ligand, Flt3 Ligand, SL cytokine
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
W19353A_PE_-FLT3L_FC_082824
Recombinant human IL-7 (Cat. No. 581902) stimulated (15 ng/mL for 3 days) human peripheral blood mononuclear cells were stained with anti-human CD3 (clone UCHT1) APC and anti-human FLT3L (clone W19353A) PE or rat IgG2a, κ PE isotype control (right).
  • W19353A_PE_-FLT3L_FC_082824
    Recombinant human IL-7 (Cat. No. 581902) stimulated (15 ng/mL for 3 days) human peripheral blood mononuclear cells were stained with anti-human CD3 (clone UCHT1) APC and anti-human FLT3L (clone W19353A) PE or rat IgG2a, κ PE isotype control (right).
See PE spectral data
Cat # Size Price Quantity Check Availability Save
345603 25 tests $177
Check Availability


Need larger quantities of this item?
Request Bulk Quote
345604 100 tests $396
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Human FLT3L was initially cloned from a T cell cDNA library using a mouse probe; the human and mouse FLT3L proteins share 72% amino acid identity. FLT3L is synthesized as a type I membrane-bound protein, which is cleaved to become a soluble growth factor. An additional soluble form of FLT3L has been reported as a result of alternative splicing. TACE (ADAM17) plays a key role in the ectodomain shedding of FLT3L. In fact, serum FLT3L levels are decreased in TACE deficient mice.

FLT3L is crucial for the development of the two main subsets of dendritic cells (DCs): conventional DCs (cDCs) and plasmacytoid DCs (pDCs). Changes in the development or number of DCs can alter T cell immunity and tolerance. A feedback loop between DCs and Tregs is regulated via FLT3L, as it has been shown that the increase in Tregs induced by DC expansion delays the onset of type 1 autoimmune diabetes and IBD in mice. FLT3L also facilitates formation of Tregs and thus, reduces severity of antigen-induced arthritis in mice. FLT3L deficiency in humans has been shown to result in bone marrow hypoplasia, with low levels of hematopoietic progenitors (particularly myeloid and B cell progenitors). FLT3L is elevated in the synovial fluid of rheumatoid arthritis (RA) patients and FLT3L has been included in panels of preclinical markers for predicting the possible development of RA. The innate sensing pathway triggered by Plasmodium infection regulates DC homeostasis and adaptive immunity via FLT3L release. High levels of FLT3L and increased DCs have been detected in humans and mice during Plasmodium infection.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Human
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Human FLT3L transfected cell line
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation
The antibody was purified by affinity chromatography and conjugated with PE under optimal conditions.
Concentration
Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µL per million cells in 100 µL staining volume or 5 µL per 100 µL of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Surface staining in fixed cells may result in lower signal compared to unfixed cells.

Antigen Details

Structure
P49771
Distribution

Hematopoietic precursors, stromal bone marrow cells, T Lymphocytes

Function
FLT3L stimulates the proliferation of hematopoietic precursors and development of B cells and dendritic cells. Additionally, FLT3L is also required for the development of monocytes in humans and NK cells in mice. FLT3L regulates the homeostatic feedback loop between DCs and Tregs.
Interaction
Hematopoietic stem progenitor cells, progenitor cells, DCs, monocytes, B cells, and NK cells
Ligand/Receptor
Fms related receptor tyrosine kinase 3, FLT3, CD135
Cell Type
Embryonic Stem Cells, Hematopoietic stem and progenitors
Biology Area
Stem Cells
Molecular Family
Cytokines/Chemokines, Growth Factors
Antigen References
  1. Hannum C, et al. 1994. Nature. 368:643-8.
  2. Waskow C. 2008. Nat Immunol. 9:676-83.
  3. Darrasse-Jèse G, et al. 2009. J Exp Med. 206:1853-62.
  4. Horiuchi K, et al. 2009. J Immunol. 182:7408-14.
  5. Svensson MN, et al. 2013. PLoS One. 8:e54884.
  6. Guermonprez P, et al. 2013. Nat Med. 19:730-8.
  7. Chklovskaia E, et al. 2001. Blood. 97:1027-34.
  8. Momenilandi M, et al. 2024. Cell. 187:2817.
Gene ID
2323 View all products for this Gene ID
UniProt
View information about FLT3L on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.
Go To Top Version: 1    Revision Date: 08/28/2024

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere

Login/Register
Remember me
Forgot your password? Reset Password
Request an Account